| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/16/2011 | CN101032474B Rasagiline transparent patch for curing and preventing neurological diseases and the preparing method thereof |
| 02/15/2011 | US7888487 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/15/2011 | US7888473 Non-functional P2X7 receptor |
| 02/15/2011 | US7888460 a mutant gliadin protein with the mutation in the epitope 62PQPQLPY68, or a fragment of such mutant protein (non-glidin sequence), decreases the ability of the epitope to induce a Tcell or antibody response |
| 02/15/2011 | US7888391 Method for reducing the severity of neurological disorders |
| 02/15/2011 | US7888388 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888291 Substrates and assays for β-secretase |
| 02/15/2011 | US7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 02/15/2011 | US7887816 Attenuated microorganisms for the treatment of infection |
| 02/15/2011 | US7887807 Anti-IL-12 antibodies and compositions |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | CA2624949C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2529452C Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 02/15/2011 | CA2491172C Microcapsules for the delayed, controlled release of perindopril |
| 02/15/2011 | CA2483594C Use of edg receptor binding agents in cancer |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2480560C .kappa.-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2461572C Polycyclic compounds having anti-tumor activity |
| 02/15/2011 | CA2455453C Taxol enhancer compounds |
| 02/15/2011 | CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2451043C Enhanced drug delivery in transdermal systems |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/15/2011 | CA2433535C Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2377085C Substituted benzimidazoles |
| 02/15/2011 | CA2373554C Process for the preparation and purification of thiol-containing maytansinoids |
| 02/15/2011 | CA2334863C Antithrombotic compounds |
| 02/15/2011 | CA2247420C Combination therapy for osteoporosis |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/10/2011 | WO2011017319A1 Methods of treating disorders associated with protein polymerization |
| 02/10/2011 | WO2011016561A1 Dna capable of inducing osteoblast-specific expression, and nucleotide sequence for same |
| 02/10/2011 | WO2011016559A1 Heterocyclic compound and use thereof |
| 02/10/2011 | WO2011016558A1 Method for producing glucosylceramide-containing material |
| 02/10/2011 | WO2011016528A1 Aminopyrazole derivative |
| 02/10/2011 | WO2011016504A1 Nitrogenous-ring acylguanidine derivative |
| 02/10/2011 | WO2011016501A1 Prophylactic or therapeutic agent for cancer |
| 02/10/2011 | WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity |
| 02/10/2011 | WO2011016468A1 Benzyl piperidine compound |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2011016351A1 Dna synthase inhibitors |
| 02/10/2011 | WO2011016234A1 Picolinamide derivatives as ttx-s blockers |
| 02/10/2011 | WO2011016220A1 Dipeptidyl peptidase-4 inhibitor |
| 02/10/2011 | US20110035023 Prosthesis for promoting the in vivo reconstruction of a hollow organ or a portion of a hollow organ |
| 02/10/2011 | US20110034559 Cell Repair And Regeneration By Suramin And Related Polysulfonated Naphthylureas |
| 02/10/2011 | US20110034552 Long-chain oxyaminopolyol based gelator and gel |
| 02/10/2011 | US20110034541 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 02/10/2011 | US20110034535 Positive controls for expression modulating experiments |
| 02/10/2011 | US20110034527 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/10/2011 | US20110034518 Pharmaceutical composition |
| 02/10/2011 | US20110034513 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production |
| 02/10/2011 | US20110034509 Beta-2-Adrenoreceptor Agonists |
| 02/10/2011 | US20110034458 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 02/10/2011 | US20110034449 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/10/2011 | US20110034444 Selected cgrp antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 02/10/2011 | US20110034441 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
| 02/10/2011 | US20110034435 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers |
| 02/10/2011 | US20110034400 Compositions and methods for analyzing bacterial adherence and anti-adherence to mucus, epithelial cells and other cells |
| 02/10/2011 | US20110034390 Peptides, compositions, and uses thereof |
| 02/10/2011 | US20110034388 Collagen and fibrin microthreads in a discrete thread model of in vitro acl scaffold regeneration |
| 02/10/2011 | US20110034379 Gastrin Compositions And Formulations, And Methods Of Use And Preparation |
| 02/10/2011 | US20110034370 Bis-met histones |
| 02/10/2011 | US20110033595 Fatty acid fractionation process, fatty acid products and use thereof |
| 02/10/2011 | US20110033557 Pharmaceutical composition and diagnostic and therapeutic use thereof |
| 02/10/2011 | US20110033470 Human G-Protein Coupled Receptor |
| 02/10/2011 | US20110033466 Human transcriptomes |
| 02/10/2011 | US20110033458 Combinations comprising epothilones and pharmaceutical uses thereof |
| 02/10/2011 | US20110033457 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 02/10/2011 | US20110033456 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 02/10/2011 | US20110033427 Expansion Of Renewable Stem Cell Populations |
| 02/10/2011 | US20110033385 Methods and apparatus for non-invasive determination of patient's blood conditions |
| 02/10/2011 | CA2770409A1 Nitrogenous-ring acylguanidine derivative |
| 02/10/2011 | CA2770195A1 Aminopyrazole derivative |
| 02/10/2011 | CA2769977A1 Benzylpiperidine compound |
| 02/09/2011 | EP2281901A2 Anti-tumour pharmaceutical composition with angiogenesis inhibitors |
| 02/09/2011 | EP2281837A2 Antigen binding domains from fish |
| 02/09/2011 | EP2281828A2 Compositions comprising modified erythropoietin |
| 02/09/2011 | EP2281823A2 Anti-inflammatory and analgesic piperidine derivatives |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281624A1 Filtration method |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281576A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
| 02/09/2011 | EP2281574A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2281563A1 2,4-Pyrimidinediamine compounds and their uses |
| 02/09/2011 | EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy |
| 02/09/2011 | EP2281003A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 02/09/2011 | EP2280700A2 Combination of dronedarone with at least one diuretic, and therapeutic use thereof |
| 02/09/2011 | EP2280696A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 02/09/2011 | EP1965797B1 Reduction of dizziness, a side effect associated with pirfenidone therapy |
| 02/09/2011 | EP1947111B1 Mucin glycoprotein and use thereof |
| 02/09/2011 | EP1487825B1 Processes for the preparation of synthetic derivatives of dibenzylbutyrolactonic lignans having anti-chagas properties |
| 02/09/2011 | EP1451192B1 Novel crystalline compound |